Mark C. Wiggins, EVP Corporate and Business Development at BIOGEN IDEC INC. (BIIB), sold 6,869 shares at $57.41 ($393K) on 2007-12-31, disclosed to the SEC on 2008-01-03.
Scheduled sale ($393k) by EVP Corporate and Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.96 | 300 | $17K | 4.3% |
| 2 | $57.02 | 100 | $6K | 1.5% |
| 3 | $57.07 | 400 | $23K | 5.8% |
| 4 | $57.12 | 300 | $17K | 4.4% |
| 5 | $57.13 | 200 | $11K | 2.9% |
| 6 | $57.15 | 100 |
| $6K |
| 1.5% |
| 7 | $57.16 | 400 | $23K | 5.8% |
| 8 | $57.17 | 1,169 | $67K | 17.0% |
| 9 | $57.18 | 300 | $17K | 4.4% |
| 10 | $57.19 | 100 | $6K | 1.5% |
| 11 | $57.21 | 300 | $17K | 4.4% |
| 12 | $57.22 | 400 | $23K | 5.8% |
| 13 | $57.23 | 700 | $40K | 10.2% |
| 14 | $57.24 | 100 | $6K | 1.5% |
| 15 | $57.29 | 300 | $17K | 4.4% |
| 16 | $57.34 | 500 | $29K | 7.3% |
| 17 | $57.35 | 300 | $17K | 4.4% |
| 18 | $57.36 | 200 | $11K | 2.9% |
| 19 | $57.41 | 400 | $23K | 5.8% |
| 20 | $57.47 | 300 | $17K | 4.4% |
| Total | $57.22 avg | 6,869 | $393K | 100% |
| Filing → |
| ZGNX | BUY | 2020-03-24 | $51K | — | Filing → |
| TCON | BUY | 2020-01-24 | $20K | — | Filing → |
| ZGNX | SELL | 2019-08-12 | $313K | — | Filing → |